All Posts IMO. Do your own research
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, that’s very interesting.
GLTA shareholders
Interesting. Thanks for the info. Hopefully they get things done in a timely manner
Looking forward to positive updates from XXII and a good 2022
GLTA shareholders
Fully under control? Did they project milestone dates or RVVTF?
Looks like the market did not take the news well. Hopefully we see a reversal and Green day soon
GLTA Shareholders
Interesting points. Is it 700 more patients? In any case, I think RVVTF should consider hiring a dedicated and top notch program manager to keep the trials and associated activities on track and on schedule
Looking forward to an update from the CEO.
Looks like PPS moving up
Perhaps, especially from any forward thinking organization that’s currently in the industry and understands product positioning and is also looking to promote goodwill
Happy holidays and GLTA shareholders
Good PPS movement today. Looking forward to the company’s updates next week and beyond and perhaps greater media coverage.
It will be interesting to see if XXII proceeds alone or partners with a forward thinking organization that understands product positioning, etc.
GLTA shareholders
Looks like XXII just tweeted they will be on @benzinga at 12 noon today to discuss MRTP
XXII always seems to have timing issues. Perhaps they need to take advantage of the long weekend and get the word out on mainstream media?
It’s great news for XXII, it’s shareholders and the smoking population that want to quit. The market response right now is underwhelmed as PPS is not really moving up. Perhaps when XXII gets the word out it will change?
Maybe that’s what the studies showed and why it may work?
Also, I think when they issue EUA’s they have similar wording on evaluation, etc. although I’m not sure
GLTU and all shareholders and those who want to quit smoking
GLTU and all shareholders. Let’s hope this makes a positive impact in the world
Awesome news!!! Let’s go XXII
Looking forward to more updates and info from XXII
Congratulations to all shareholders!!! Especially those that have held for a long time
Maybe they have more info than that?
In any case, I think a PR is appropriate on its purpose, timing, etc.
Did XXII put out a PR on it? If not, perhaps they should?
Would be nice to get an update on all the Q4 2021 milestones this week. Especially the Buc trials
Would be nice to see MRTP approval soon and in 2021.
GLTA shareholders
Would be nice to get an update from the CEO.
GLTA shareholders
Looking forward to good news soon.
GLTA shareholders
Well, perhaps that could make a big difference?
Curious if they had many shareholders with numerous restricted shares and shareholders like NGCG?
I figured that and perhaps that’s what they’re waiting for before any big news?
Curious when those restricted shares issued in February become unrestricted
Thanks for the info. Let’s hope he does something and soon
GLTA shareholders
Hopefully MRTP is approved soon.
GLTA shareholders
Perhaps the CEO can provide an update to shareholders?
Let’s hope he does something positive for shareholders soon. Ideally in 2021
GLTU
Interesting. Wonder if Daniel is doing anything to increase shareholders value and equity?
Would be great to get positive anti inflammatory results at 800 patients and DSMB giving the nod for EUA at 800.
If they have enough info at 800 for the potential viral load and anti viral properties that’s great. If not,
it would be good if they recommend EUA at 800 and let the trials continue to 1,000 to address the potential viral load and anti viral properties and usage.
Yes. I heard that. I’m wondering if they would allow for an EUA at 800 patients as an anti inflammatory while they continue to analyze the viral loading and potential anti viral properties and then ANOTHER EUA at 1,000 patients for both anti inflammatory AND anti viral usage?
Very nice. Good questions and thoughts from BMT.
I’m not sure if I missed it; however, I wonder if the results at 800 patients were good if the DSMB would recommend going for EUA immediately while continuing the trials to 1,000 patients for the antiviral aspects including the additional viral load testing and analysis?